353 related articles for article (PubMed ID: 16230392)
1. Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development.
Sung YM; He G; Fischer SM
Cancer Res; 2005 Oct; 65(20):9304-11. PubMed ID: 16230392
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development.
Sung YM; He G; Hwang DH; Fischer SM
Oncogene; 2006 Sep; 25(40):5507-16. PubMed ID: 16607275
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin receptor EP2 is responsible for cyclooxygenase-2 induction by prostaglandin E2 in mouse skin.
Ansari KM; Sung YM; He G; Fischer SM
Carcinogenesis; 2007 Oct; 28(10):2063-8. PubMed ID: 17277233
[TBL] [Abstract][Full Text] [Related]
4. Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin.
Guo H; Miao H; Gerber L; Singh J; Denning MF; Gilliam AC; Wang B
Cancer Res; 2006 Jul; 66(14):7050-8. PubMed ID: 16849550
[TBL] [Abstract][Full Text] [Related]
5. Papilloma development is delayed in osteopontin-null mice: implicating an antiapoptosis role for osteopontin.
Hsieh YH; Juliana MM; Hicks PH; Feng G; Elmets C; Liaw L; Chang PL
Cancer Res; 2006 Jul; 66(14):7119-27. PubMed ID: 16849558
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of the EP1 receptor for prostaglandin E2 promotes skin tumor progression.
Surh I; Rundhaug J; Pavone A; Mikulec C; Abel E; Fischer SM
Mol Carcinog; 2011 Jun; 50(6):458-68. PubMed ID: 21268127
[TBL] [Abstract][Full Text] [Related]
7. Sequential down-regulation of E-cadherin with squamous cell carcinoma progression: loss of E-cadherin via a prostaglandin E2-EP2 dependent posttranslational mechanism.
Brouxhon S; Kyrkanides S; O'Banion MK; Johnson R; Pearce DA; Centola GM; Miller JN; McGrath KH; Erdle B; Scott G; Schneider S; VanBuskirk J; Pentland AP
Cancer Res; 2007 Aug; 67(16):7654-64. PubMed ID: 17699770
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E receptor EP3 deficiency modifies tumor outcome in mouse two-stage skin carcinogenesis.
Shoji Y; Takahashi M; Takasuka N; Niho N; Kitamura T; Sato H; Maruyama T; Sugimoto Y; Narumiya S; Sugimura T; Wakabayashi K
Carcinogenesis; 2005 Dec; 26(12):2116-22. PubMed ID: 16051640
[TBL] [Abstract][Full Text] [Related]
9. The effect of PPARgamma ligands on UV- or chemically-induced carcinogenesis in mouse skin.
He G; Muga S; Thuillier P; Lubet RA; Fischer SM
Mol Carcinog; 2005 Aug; 43(4):198-206. PubMed ID: 15864802
[TBL] [Abstract][Full Text] [Related]
10. Dietary grape seed proanthocyanidins inhibit 12-O-tetradecanoyl phorbol-13-acetate-caused skin tumor promotion in 7,12-dimethylbenz[a]anthracene-initiated mouse skin, which is associated with the inhibition of inflammatory responses.
Meeran SM; Vaid M; Punathil T; Katiyar SK
Carcinogenesis; 2009 Mar; 30(3):520-8. PubMed ID: 19158151
[TBL] [Abstract][Full Text] [Related]
11. Altered glucocorticoid receptor expression and function during mouse skin carcinogenesis.
Budunova IV; Carbajal S; Kang H; Viaje A; Slaga TJ
Mol Carcinog; 1997 Mar; 18(3):177-85. PubMed ID: 9115588
[TBL] [Abstract][Full Text] [Related]
12. The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia.
Chang SH; Ai Y; Breyer RM; Lane TF; Hla T
Cancer Res; 2005 Jun; 65(11):4496-9. PubMed ID: 15930264
[TBL] [Abstract][Full Text] [Related]
13. The effect of cyclooxygenase-2 overexpression on skin carcinogenesis is context dependent.
Rundhaug JE; Pavone A; Kim E; Fischer SM
Mol Carcinog; 2007 Dec; 46(12):981-92. PubMed ID: 17583568
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
La E; Muga SJ; Locniskar MF; Fischer SM
Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 receptor subtype 2 (EP2) null mice are protected against murine lung tumorigenesis.
Keith RL; Geraci MW; Nana-Sinkam SP; Breyer RM; Hudish TM; Meyer AM; Malkinson AM; Dwyer-Nield LD
Anticancer Res; 2006; 26(4B):2857-61. PubMed ID: 16886605
[TBL] [Abstract][Full Text] [Related]
16. Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis.
Tiano HF; Loftin CD; Akunda J; Lee CA; Spalding J; Sessoms A; Dunson DB; Rogan EG; Morham SG; Smart RC; Langenbach R
Cancer Res; 2002 Jun; 62(12):3395-401. PubMed ID: 12067981
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of tumor formation by topical administration of 15-deoxy-delta12,14-prostaglandin J2 in a model of skin carcinogenesis.
Millán O; Rico D; Peinado H; Zarich N; Stamatakis K; Pérez-Sala D; Rojas JM; Cano A; Boscá L
Carcinogenesis; 2006 Feb; 27(2):328-36. PubMed ID: 16113051
[TBL] [Abstract][Full Text] [Related]
18. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.
Chan KS; Sano S; Kataoka K; Abel E; Carbajal S; Beltran L; Clifford J; Peavey M; Shen J; Digiovanni J
Oncogene; 2008 Feb; 27(8):1087-94. PubMed ID: 17700521
[TBL] [Abstract][Full Text] [Related]
19. p44 mitogen-activated protein kinase (extracellular signal-regulated kinase 1)-dependent signaling contributes to epithelial skin carcinogenesis.
Bourcier C; Jacquel A; Hess J; Peyrottes I; Angel P; Hofman P; Auberger P; Pouysségur J; Pagès G
Cancer Res; 2006 Mar; 66(5):2700-7. PubMed ID: 16510590
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of protein kinase Calpha in mice results in impairment of epidermal hyperplasia and enhancement of tumor formation in two-stage skin carcinogenesis.
Hara T; Saito Y; Hirai T; Nakamura K; Nakao K; Katsuki M; Chida K
Cancer Res; 2005 Aug; 65(16):7356-62. PubMed ID: 16103087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
